NCI
NIH Earmarks $38M for Consortium Studying Polygenic Risk Scores in Diverse Populations
The consortium aims to develop and evaluate methods for calculating polygenic risk scores for specific diseases, particularly for people of different ancestries.
Crown Bioscience Licenses Cell Line Portfolio From NCI, ATCC
The ATCC deal gives CrownBio access to more than 140 cell lines now and 4,000 cell lines in the future, and the NCI deal gives the firm access to 100 cell lines.
Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk
The health system will partner with the NCI to look for new cancer risk variants in a large population biobank, in the hopes of improving screening and care.
Genomic Effects of Radiation From Chernobyl Nuclear Disaster Examined in New Studies
The studies examined mutational effects of ionizing radiation in exposed children who developed thyroid cancer and in offspring of exposed parents.
NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths
At the AACR Annual Meeting, Sharpless said NCI should focus on improving early screening, access to trials, and development of advanced drugs to realize President Biden's goal of eradicating cancer.